TaiMed Biologics (ROCO:4147) Interest Expense : NT$-15.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. TaiMed Biologics's interest expense for the three months ended in Mar. 2024 was NT$ -3.7 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-15.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. TaiMed Biologics's Operating Income for the three months ended in Mar. 2024 was NT$ -37.1 Mil. TaiMed Biologics's Interest Expense for the three months ended in Mar. 2024 was NT$ -3.7 Mil. TaiMed Biologics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TaiMed Biologics Interest Expense Historical Data

The historical data trend for TaiMed Biologics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics Interest Expense Chart

TaiMed Biologics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.36

-4.09

-7.44

-10.10

-14.81

TaiMed Biologics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-3.53	-3.75	-3.77	-3.76	-3.70

TaiMed Biologics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-15.0 Mil.

TaiMed Biologics (ROCO:4147) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TaiMed Biologics's Interest Expense for the three months ended in Mar. 2024 was NT$-3.7 Mil. Its Operating Income for the three months ended in Mar. 2024 was NT$-37.1 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was NT$514.3 Mil.

TaiMed Biologics's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

TaiMed Biologics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

TaiMed Biologics (ROCO:4147) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492

Website

http://www.taimedbiologics.com

TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines for infectious disease. It capitalizes on its intellectual, extensive expertise, and management resources to develop a health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-365, VRC07-523LS, and others.

TaiMed Biologics (ROCO:4147) Headlines

No Headlines